Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans

References

• Tracey KJ. Reflex control of immunity. Nat Rev Immunol. 2009; 9:418–428.
   PubMed Web of Science ®Google Scholar
• Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 2001;38:581–587.
   PubMed Web of Science ®Google Scholar
• Leibowitz A, Schiffrin EL. Immune mechanisms in hypertension. Curr Hypertens Rep. 2011;13:465–472.
   PubMed Web of Science ®Google Scholar
• Harrison DG, Guzik TJ, Lob HE, et al. Inflammation, immunity, and hypertension. Hypertension. 2011;57:132–140.
   PubMed Web of Science ®Google Scholar
• Harrison DG, Vinh A, Lob H, et al. Role of the adaptive immune system in hypertension. Curr Opin Pharmacol. 2010;10:203–207.
   PubMed Web of Science ®Google Scholar
• Blake GJ1, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001;89:763–771.
   PubMed Web of Science ®Google Scholar
• Sesso HD, Buring JE, Rifai N, et al. C-reactive protein and the risk of developing hypertension. JAMA.2003;290:2945–2951.
   PubMed Web of Science ®Google Scholar
• Preston RA, Ledford M, Materson BJ, et al. Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor. J Hypertens. 2002;20:871–877.
   PubMed Web of Science ®Google Scholar
• Blake GJ, Rifai N, Buring JE, et al. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation. 2003;108:2993–2999.
   PubMed Web of Science ®Google Scholar
• Blann AD, Tse W, Maxwell SJ, et al. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens. 1994;12:925–928.
   PubMed Web of Science ®Google Scholar
• Ferri C, Desideri G, Baldoncini R, et al. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes.1998;47:660–667.
   PubMed Web of Science ®Google Scholar
• DeSouza CA, Dengel DR, Macko RF, et al. Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am J Hypertens. 1997;10:1335–1341.
   PubMed Web of Science ®Google Scholar
• Buemi M, Allegra A, Aloisi C, et al. Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensive patients. Hypertension.1997;30:845–847.
   PubMed Web of Science ®Google Scholar
• Ferri C, Bellini C, Desideri G, et al. Clustering of endothelial markers of vascular damage in human salt-sensitive hypertension: influence of dietary sodium load and depletion. Hypertension. 1998;32:862–868.
   PubMed Web of Science ®Google Scholar
• Verhaar MC, Beutler JJ, Gaillard CA, et al. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. J Hypertens. 1998;16:45–50.
   PubMed Web of Science ®Google Scholar
• De Ciuceis C, Rossini C, Tincani A, et al. Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension. Blood Press.2016;25:337–343.
   PubMed Web of Science ®Google Scholar
• De Ciuceis C, Salvetti M, Rossini C, et al. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. J Hypertens. 2014;32:565–574.
   PubMed Web of Science ®Google Scholar
• Bautista LE, Vera LM, Arenas IA, et al. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19:149–154.
   PubMed Web of Science ®Google Scholar
• Virdis A, Schiffrin EL. Vascular inflammation: a role in vascular disease in hypertension? Curr Opin Nephrol Hypertens. 2003;12:181–187.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. T lymphocytes: a role in hypertension? Curr Opin Nephrol Hypertens. 2010;19:181–186.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. Immune mechanisms in hypertension and vascular injury. Clin Sci. 2014;126:267–274.
   PubMed Web of Science ®Google Scholar
• Viel EC, Lemarié CA, Benkirane K, et al. Immune regulation and vascular inflammation in genetic hypertension. Am J Physiol Heart Circ Physiol. 2010; 298:H938–H9344.
   PubMed Web of Science ®Google Scholar
• Barhoumi T, Kasal DA, Li MW, et al. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension. 2011;57:469–476.
   PubMed Web of Science ®Google Scholar
• De Ciuceis C, Rossini C, Airò P, et al. Relationship between different subpopulations of circulating CD4+ T-lymphocytes and microvascular structural alterations in humans. AJHYPE. 2017;30:51–60.
   Web of Science ®Google Scholar
• Itani HA, McMaster WG, Jr., Saleh MA, et al. Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans. Hypertension. 2016;68:123–132.
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449–2460.
   PubMed Web of Science ®Google Scholar
• Chan CT, Sobey CG, Lieu M, et al. Obligatory role for B cells in the development of angiotensin II-Dependent Hypertension. Hypertension. 2015;66:1023–1033.
   PubMed Web of Science ®Google Scholar
• Caillon A, Schiffrin EL. Role of inflammation and immunity in hypertension: recent epidemiological, laboratory, and clinical evidence. Curr Hypertens Rep. 2016;18:21–25.
   PubMed Web of Science ®Google Scholar
• Harrison DG, Gongora MC. Oxidative stress and hypertension. Med Clin North Am. 2009;93:621–635.
   PubMed Web of Science ®Google Scholar
• Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol. 2004;122:339–352.
   PubMed Web of Science ®Google Scholar
• Jackson SH, Devadas S, Kwon J, et al. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol. 2004;5:818–827.
   PubMed Web of Science ®Google Scholar
• Virdis A, Savoia C, Grassi G, et al. Evaluation of microvascular structure in humans: a 'state-of-the-art' document of the Working Group on Macrovascular and Microvascular Alterations of the Italian Society of Arterial Hypertension. J Hypertens. 2014;32:2120–2129.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Porteri E, Duse S, et al. Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry. J Hypertens. 2012;30:1169–1175.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, Task Force Members, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–1357.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Porteri E, De Ciuceis C, et al. Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing’s syndrome. J Clin Endocrinol Metab. 2009;94:5010–5018.
   PubMed Web of Science ®Google Scholar
• De Ciuceis C, Rossini C, Porteri E, et al. Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery. Blood Press. 2013;22:165–172.
   PubMed Web of Science ®Google Scholar
• De Ciuceis C, Porteri E, Rizzoni D, et al. Effects of weight loss on structural and functional alterations of subcutaneous small arteries in obese patients. Hypertension. 2011;58:29–36.
   PubMed Web of Science ®Google Scholar
• Taleb S, Tedgui A, Mallat Z. Regulatory T-cell immunity and its relevance to atherosclerosis. J Intern Med. 2008;263:489–499.
   PubMed Web of Science ®Google Scholar
• Carnevale D, Lembo D. Immunological aspects of hypertension. High Blood Press Cardiovasc Prev. 2016;23:91–95.
   PubMedGoogle Scholar
• Schiffrin EL. Immune modulation of resistance artery remodelling. Basic Clin Pharmacol Toxicol. 2012;110:70–72.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. The immune system: role in hypertension. Can J Cardiol. 2013;29:543–548.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. Immune mechanisms in hypertension: how do T-regulatory lymphocytes fit in? J Hypertens. 2013;31:1944–1945.
   PubMed Web of Science ®Google Scholar
• Kassan M, Wecker A, Kadowitz P, et al. CD4 + CD25 + Foxp3 regulatory T cells and vascular dysfunction in hypertension. J Hypertens. 2013;31:1939–1943.
   PubMed Web of Science ®Google Scholar
• Kassan M, Galan M, Partyka M, et al. Interleukin-10 released by CD4 + CD25+ natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler Thromb Vasc Biol. 2011;11:2534–2542.
   Web of Science ®Google Scholar
• Zhang J, Crowley SD. Role of T lymphocytes in hypertension. Curr Opin Pharmacol. 2015;21:14–19.
   PubMed Web of Science ®Google Scholar
• Youn J-C, Yu HT, Lim BJ, et al. Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension. 2013;62:126–133.
   PubMed Web of Science ®Google Scholar
• Duftner C, Seiler R, Klein-Weigel P, et al. High prevalence of circulating CD4 + CD28- T-cells in patients with small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2005;25:1347–1352.
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Goronzy JJ, Yang H, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;101:2883–2888.
   PubMed Web of Science ®Google Scholar
• Gerli R, Schillaci G, Giordano A, et al. CD4 + CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation. 2004;109:2744–2748.
   PubMed Web of Science ®Google Scholar
• Madhur MS, Lob HE, McCann LA, et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension. 2010;55:500–507.
   PubMed Web of Science ®Google Scholar
• Cheng X, Yu X, Ding YJ, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol. 2008;127:89–97.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhai X, Chen X, et al. Dysregulation of circulating CD4 + CXCR5+ T cells in type 2 diabetes mellitus. APMIS. 2015;123:146–151.
   PubMed Web of Science ®Google Scholar
• Harazny JM, Ritt M, Baleanu D, et al. Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension. 2007;50:623–629.
   PubMed Web of Science ®Google Scholar
• De Miguel C, Das S, Lund H, et al. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1136–R1142.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Iturbe B, Pons H, Quiroz Y, et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int. 2001;59:2222–2232.
   PubMed Web of Science ®Google Scholar